Hum. Reprod. Advance Access originally published online on June 24, 2004
Human Reproduction 2004 19(9):2031-2035; doi:10.1093/humrep/deh359
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report
1 Institute of Reproductive Medicine, Salt Lake, Kolkata 700091, 2 School of Medical Science and Technology, Indian Institute of Technology, Kharagpur 721302 and 3 Reproductive Biology Research, Indian Institute of Chemical Biology, Jadavpur, Kolkata 700032, West Bengal, India
4 To whom correspondence should be addressed at: Indian Institute of Chemical Biology, Jadavpur, Kolkata 700032, West Bengal, India.or; Email: syednkabir{at}yahoo.com
BACKGROUND: Use of letrozole, a selective inhibitor of aromatase, reduces the gonadotrophin dose required to induce follicular maturation. We evaluated whether incorporation of letrozole could be an effective low-cost IVF protocol for poor responders. METHODS: A randomized, controlled, single-blind trial was conducted in the Assisted Reproduction Unit, Institute of Reproductive Medicine, Kolkata, India. Thirty-eight women with a history of poor ovarian response to gonadotrophins were recruited. Thirteen women (Let-FSH group) received letrozole 2.5 mg daily from day 3–7, and recombinant FSH (rFSH) 75 IU/day on days 3 and 8; and 25 women (GnRH-ag-FSH group) underwent long GnRH agonist protocol and stimulated with rFSH (300–450 IU/day). Ovulation was triggered by 10 000 IU of HCG followed by IVF-embryo transfer. The main outcome measures were total dose of rFSH (IU/cycle), terminal estradiol (E2) (pg/ml), numbers of follicles, oocytes retrieved and transferable embryo, endometrial thickness (mm), and pregnancy rate. RESULTS: Compared with the GnRH-ag-FSH group (2865±228 IU), the Let-FSH group (150±0 IU) received a significantly (P<0.001) lower total dose of FSH. Except for terminal E2, which was significantly higher (P<0.001) in the GnRH-ag-FSH group (380±46 pg/ml) than the Let-FSH group (227±45 pg/ml), the treatment outcomes in all other respects, including pregnancy rate, were statistically comparable. CONCLUSIONS: Adjunctive use of letrozole may form an effective means of low-cost IVF protocol in poorly responding women.
Key words: aromatase inhibitor/letrozole/low-cost IVF/poor ovarian responders
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N.P. Polyzos, D. Mauri, and S. Tzioras Letrozole in ovulation induction: time to make decisions Hum. Reprod. Update, March 1, 2009; 15(2): 263 - 264. [Full Text] [PDF]
|
|
|
|
|
|
M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser Mild ovarian stimulation for IVF Hum. Reprod. Update, January 1, 2009; 15(1): 13 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Requena, J. Herrero, J. Landeras, E. Navarro, J. L. Neyro, C. Salvador, R. Tur, J. Callejo, M. A. Checa, M. Farre, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis Hum. Reprod. Update, November 1, 2008; 14(6): 571 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barad and N. Gleicher Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF Hum. Reprod., November 1, 2006; 21(11): 2845 - 2849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Casper and M. F. M. Mitwally Aromatase Inhibitors for Ovulation Induction J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 760 - 771. [Abstract] [Full Text] [PDF]
|
|